AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Find out which credit cards offer the highest cash back rates to maximize your rewards on everyday purchases.
27,818 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
When a public figure’s daughter is hurt in an e-bike crash, it’s a reminder that accidents touch every household. Thi...
Kick back this weekend with 10 thoughtful weekend reads that bridge big ideas and real-world investing. Each piece of...
A downtown Pittsburgh convenience store is at the center of allegations that SNAP benefits were converted to cash and...
A fresh rally in fintech names has traders watching carefully. This article explores why fiserv stock just popped, wh...
Mega-IPOs grab headlines, but what sticks after the first week? This article breaks down the five biggest IPOs in his...
A young dairy operation highlights how rapid growth can outpace cash flow, triggering renewed scrutiny of finance and...
As peace hopes buoy mood, major indices climb and big tech names surge. Discover what drove the stock market today, j...
Many investors sit on cash waiting for rates to fall. This guide shows why stopping the wait and locking in 4% on new...
When a global star resurfaces at a major awards show, money, trust, and hype collide. This piece breaks down the cont...
Netflix is tightening access to viewing data as it trims public reporting on audience insights, prompting a cautious ...
Peloton has faced a brutal selloff, but the story isn’t finished. This article dives into whether Peloton is broken o...